Compound 877
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)cc1
- IUPAC name:
4-[4-[2-[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethoxy]phenyl]benzoic acid
- InChi:
InChI=1S/C33H35NO5/c1-34(2)22-6-21-33(37,28-7-4-3-5-8-28)29-15-19-31(20-16-29)39-24-23-38-30-17-13-26(14-18-30)25-9-11-27(12-10-25)32(35)36/h3-5,7-20,37H,6,21-24H2,1-2H3,(H,35,36)/t33-/m0/s1
- InChiKey:
NYJJMCPHLCWNLP-XIFFEERXSA-N
External links
168318040 |
26364071 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 525.25 g/mol | |||
HBA | 6 | |||
HBD | 2 | |||
HBA + HBD | 8 | |||
AlogP | 3.43 | |||
TPSA | 79.23 | |||
RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6126 | Ansofaxine | DB15052 | |
0.5979 | Lifibrol | DB12448 | |
0.5547 | 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid | DB04405 | |
0.5484 | Terfenadine | DB00342 | |
0.5481 | Adapalene | DB00210 | |
0.5481 | Dyclonine | DB00645 | |
0.5435 | Diphenidol | DB01231 | |
0.5400 | Clinofibrate | DB09006 | |
0.5400 | Fexofenadine | DB00950 | |
0.5368 | Chlorotoxin I-131 | DB05462 | |
0.5360 | {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DB07237 | |
0.5360 | Trifarotene | DB12808 | |
0.5298 | Adomeglivant | DB11704 | |
0.5217 | Fesoterodine | DB06702 | |
0.5210 | KH064 | DB04287 |